#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	15020	16S	1529	1529	100.0	16S.l15.c30.ctg.1	1972	754.2	1	SNP	n	C1184T	0	.	.	1184	1184	C	1403	1403	C	859	C	791	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26962	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3631	740.8	0	.	n	.	0	T695C	SNP	695	695	T	1009	1009	C	839	C	774	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26962	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3631	740.8	0	.	n	.	0	G1337A	SNP	1337	1337	G	1651	1651	A	938	A,G	871,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26962	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3631	740.8	0	.	n	.	0	T1971C	SNP	1971	1971	T	2285	2285	C	873	C,T	793,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26962	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3631	740.8	1	SNP	n	A2045G	0	.	.	2045	2045	A	2359	2359	A	824	A	767	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26962	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3631	740.8	1	SNP	n	C2597T	0	.	.	2597	2597	C	2911	2911	C	859	C	800	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_P_01364c	folP.WHO_P_01364c	1	1	27	1986	folP	852	852	100.0	folP.l6.c4.ctg.1	1494	132.3	1	SNP	p	R228S	1	.	.	682	684	AGC	983	985	AGC	217;217;219	A;G;C	204;205;207	folP.WHO_P_01364c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5236	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3429	152.4	1	SNP	p	S91F	0	.	.	271	273	TCC	531	533	TCC	177;177;176	T;C;C	165;167;165	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5236	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3429	152.4	1	SNP	p	D95G	0	.	.	283	285	GAC	543	545	GAC	179;178;178	G;A;C	167;164;168	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5236	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3429	152.4	1	SNP	p	D95N	0	.	.	283	285	GAC	543	545	GAC	179;178;178	G;A;C	167;164;168	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	539	1580	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1276	123.3	0	.	p	.	0	A39T	NONSYN	115	117	GCC	392	394	ACC	181;181;180	A,G;C;C	156,1;169;164	.	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	539	1580	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1276	123.3	0	.	p	.	0	R44H	NONSYN	130	132	CGC	407	409	CAC	178;181;182	C;A,G;C	167;164,1;168	.	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	539	1580	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1276	123.3	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	590	592	CAC	214;213;212	C;A;C	202;200;200	.	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	539	1580	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1276	123.3	1	SNP	p	G45D	0	.	.	133	135	GGC	410	412	GGC	182;181;179	G;G;C	170;168;168	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	854	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c17.ctg.1	1015	83.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4890	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2973	164.0	1	SNP	p	D86N	0	.	.	256	258	GAC	596	598	GAC	196;194;194	G;A;C	179;176;181	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4890	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2973	164.0	1	SNP	p	S87I	0	.	.	259	261	AGT	599	601	AGT	193;192;191	A;G;T	179;179;177	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4890	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2973	164.0	1	SNP	p	S87R	0	.	.	259	261	AGT	599	601	AGT	193;192;191	A;G;T	179;179;177	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4890	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2973	164.0	1	SNP	p	S87W	0	.	.	259	261	AGT	599	601	AGT	193;192;191	A;G;T	179;179;177	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4890	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2973	164.0	1	SNP	p	S88P	0	.	.	262	264	TCC	602	604	TCC	192;191;192	T;C;C	180;178;182	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4304	parE	1986	1986	100.0	parE.l6.c30.ctg.1	2536	168.3	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1505	1507	GGC	200;197;193	G;G;C	186;183;178	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	3926	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2472	158.3	1	SNP	p	A311V	0	.	.	931	933	GCA	1230	1232	GCA	211;212;214	G;C;A	199;198;199	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3926	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2472	158.3	1	SNP	p	I312M	0	.	.	934	936	ATC	1233	1235	ATC	213;213;216	A;T;C	201;200;201	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3926	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2472	158.3	1	SNP	p	V316T	0	.	.	946	948	GTG	1245	1247	GTG	211;211;213	G,T;T;G	193,1;192;195	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3926	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2472	158.3	1	SNP	p	V316P	0	.	.	946	948	GTG	1245	1247	GTG	211;211;213	G,T;T;G	193,1;192;195	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3926	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2472	158.3	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1749	1751	ACC	205;204;204	A;C;C,A	183;187;185,1	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3926	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2472	158.3	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1803	1805	GCG	168;168;172	G;C;G	150;142;147	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3926	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2472	158.3	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1803	1805	GCG	168;168;172	G;C;G	150;142;147	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3926	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2472	158.3	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1926	1928	GGC	142;141;139	G;G;C	132;131;128	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3926	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2472	158.3	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1935	1937	GGC	132;130;129	G;G;C	119;118;119	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3926	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2472	158.3	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1953	1955	CCG	96;99;103	C,G;C;G	67,3;70;75	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	5646	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3125	180.1	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1692	1694	CTG	209;212;214	C;T;G	182;188;191	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2378	porA	1146	1146	99.83	porA.l6.c4.ctg.1	1787	132.4	0	.	p	.	0	M83fs	FSHIFT	247	247	A	571	571	C	155	C	146	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2732	porB1b	1035	1035	98.57	porB1b.l15.c4.ctg.1	1452	187.2	0	.	p	.	0	R40Q	NONSYN	118	120	CGG	380	382	CAG	228;230;232	C;A,G;G	216;218,1;221	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2732	porB1b	1035	1035	98.57	porB1b.l15.c4.ctg.1	1452	187.2	0	.	p	.	0	E48G	NONSYN	142	144	GAA	404	406	GGA	247;245;247	G;G;A	224;222;223	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2732	porB1b	1035	1035	98.57	porB1b.l15.c4.ctg.1	1452	187.2	0	.	p	.	0	Y211fs	FSHIFT	631	631	T	893	893	T	227	T	213	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2732	porB1b	1035	1035	98.57	porB1b.l15.c4.ctg.1	1452	187.2	1	SNP	p	G120K	0	.	.	358	360	GGT	620	622	GGT	210;212;213	G;G;T	199;202;199	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2732	porB1b	1035	1035	98.57	porB1b.l15.c4.ctg.1	1452	187.2	1	SNP	p	A121D	0	.	.	361	363	GCC	623	625	GCC	212;210;214	G;C,G;C	200;199,1;205	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2732	porB1b	1035	1035	98.57	porB1b.l15.c4.ctg.1	1452	187.2	1	SNP	p	A121N	0	.	.	361	363	GCC	623	625	GCC	212;210;214	G;C,G;C	200;199,1;205	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10150	rpoB	4179	4179	99.98	rpoB.l15.c30.ctg.1	4953	204.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1026	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	896	113.6	1	SNP	p	V57M	1	.	.	169	171	ATG	422	424	ATG	229;226;226	A;T;G	211;210;210	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
